Company intelligence
MIDI Product Development
50 years of innovation development experience in the Medical, Life Sciences, Biotechnology & Home Healthcare markets.
About MIDI Product Development
MIDI is an award-winning strategic turnkey, FDA, and ISO compliant product development consulting firm with over 50 years of experience servicing domestic and international clientele representing medical, life sciences, and home healthcare markets. Our multi-disciplined, talented group achieves innovative results within rapid timelines under stringent regulatory constraints. MIDI's dedicated teams of research, design, and engineering professionals offer a unique combination of talent and experience, consisting of key personnel working together with a record of outstanding achievement in developing Class I, II, and III products. Our proprietary DevelopmentDNA™ approach to product development provides clients with a distinguished thoroughness in securing product results that answer market needs and increase sales as well as market share. From the first idea to the last detail, we balance technical information with a strong orientation toward user-driven design solutions. Our disciplines blend all technical/IP and human requirements. This combination is maintained with a proper balance of research methods, design, engineering, cost-effective implementation, manufacturing knowledge, DFX, regulatory compliance, and the wherewithal to use the aforementioned disciplines in concert. Our prime goal is total satisfaction for the clients we serve. We consider our clients true partners. MIDI welcomes the opportunity to hear from you and discuss your company's product development needs. Our door is open to discuss project opportunities and/or to further outline for you who we are and what we do.
Verified activity
Signals from MIDI Product Development
2 published signals
Products & Services
MIDI Product Development announced the launch of a new product line.
Reported by MIDI Product Development
Presence & Recognition
MIDI Product Development is attending the AdvaMed webinar on SaMD: From Regulatory Strategy to Market Readiness on September 16, 2026, from 12:00 PM to 1:00 PM ET.
Reported by Gregory Montalbano